Detection of Kell blood groups: Molecular methods in the diagnostic laboratory

Blood Reviews

Volumn 11, Issue 1, 1997, Pages 8-15

  Murphy, M T ^a   Fraser, R H ^a  

^a Law Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ARTICLE; BLOOD GROUP KELL SYSTEM; GENOTYPE; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR BIOLOGY; NEWBORN HEMOLYTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030973219     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(97)90002-3     Document Type: Article

References (60)

1. Coombs RR, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946; 1: 264-266.
2. Levine P, Backer M, Wigod M, Ponder R. A new human hereditary blood property (Cellano) present in 99.8% of all bloods. Science 1949; 109: 464-467.
3. Race RR, Sanger R. Blood Groups in Man, 6th edn. Oxford: Blackwell Scientific Publications, 1975.
4. Daniels G. Kell and Kx blood group systems. Human Blood Groups. Oxford: Blackwell Science, 1995: 385-420.
5. Giblett ER. A critique of the theoretical hazard of inter vs intra-racial transfusion. Transfusion 1961; 1: 233-238.
6. Mayne KM, Bowell PJ, Pratt GA. The significance of anti-Kell sensitization in pregnancy. Clin Lab Haematol 1990; 12: 379-385.
7. Bowman JM, Harman FA, Manning CR, Pollock JM. Erythroblastosis fetalis produced by anti-k. Vox Sang 1989; 56: 187-189.
8. Duguid JKM, Bromilow IM. Haemolytic disease of the newborn due to anti-k. Vox Sang 1990; 58: 69.
9. a, an antibody not usually detected in routine screening. Transfusion Med 1994; 4(Suppl.1): 48.
10. b-negative recipients at risk for having children with clinically significant hemolytic disease of the newborn. Vox Sang 1994; 66: 46-48.
11. a. Transfusion 1973; 13: 153.
12. b. Transfusion 1969; 9: 217-218.
13. a on fetal red cells. Vox Sang 1973; 24: 372-376.
14. Marsh WL, Redman CM. Review: developments in the Kell blood group system. Immunohematology 1993; 9: 1-6.
15. Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion 1990; 30: 158-167.
16. Eicher C, Kirkley K, Porter M, Kao Y. A new low frequency antigen in the Kell system: K24 (Cls). Transfusion 1985; 25: 448.
17. Allen FH, Krabbe SMR, Corcoran PA. A new phenotype (McLeod) in the Kell blood group system. Vox Sang 1961; 6: 555-560.
18. Marsh WL, Oyen R, Nichols ME, Allen FH. Chronic granulomatous disease and the Kell blood groups. Br J Haematol 1975; 29: 247-262.
19. Marsh WL, Redman CM, Kessler LA et al. K23 a low incidence antigen in the Kell blood group system identified by biochemical characterization. Transfusion 1987; 27: 36-40.
20. Redman CM, Pfeffer SR, Mukherjee TK, Nichols ME, Rubenstein P, Marsh WL. Kell blood group antigens are part of a 93 000-Dalton red cell membrane protein. J Biol Chem 1986; 261: 9521-9525.
21. Redman CM, Marsh WL, Mueller KA, Avellino GP, Johnson CL. Isolation of Kell active protein from the red cell membrane. Transfusion 1984; 24: 176-178.
22. Wallas C, Simon R, Sharpe MA, Byler C. Isolation of a Kell-reactive protein from red cell membranes. Transfusion 1986; 26: 173-176.
23. a) blood group antigen integrity. Br J Haematol 1983; 54: 573-578.
24. Lee S, Zambas E, Green ED, Redman CM. Organization of the gene encoding the human Kell blood group protein. Blood 1995; 85: 1364-1370.
25. Lee S, Zambas E, Marsh WL, Redman CM. Molecular cloning and primary structure of the Kell blood group protein. Proc Natl Acad Sci USA 1991; 88: 6353-6357.
26. Lutz P, Dzik WH. Molecular biology of red cell blood group genes. Transfusion 1992; 32: 467-483.
27. Redman CM, Marsh WL. The Kell blood group system and the McLeod phenotype. Sem Hematol 1993; 30: 209-218.
28. Lee S, Zambas E, Marsh WL, Redman CM. The human Kell blood group gene maps to 7q33 and its expression is restricted to erythroid cells. Blood 1993; 81: 2804-2809.
29. Murphy MT, Morrison N, Miles JS, Fraser RH, Spurr NK, Boyd E. Regional chromosomal assignment of the Kell blood group locus (KEL) to chromosome 7q33-q35 by fluorescence in situ hybridization: evidence for the polypeptide nature of antigenic variation. Hum Genet 1993; 91: 585-588.
30. Purohit KR, Weber JL, Ward LJ, Keats BJB. The Kell blood group locus is close to the cystic fibrosis locus on chromosome 7. Hum Genet 1992; 89: 457-458.
31. Lee S, Wu X, Son S et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996; 36: 490-494.
32. Lee S, Wu X, Reid M, Zelinski T, Redman CM. Molecular basis of the Kell (K1) phenotype. Blood 1995; 85: 912-916.
33. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
34. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
35. Lee S, Bennett PR, Overton T, Warwick R, Wu X, Redman CM. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996; 175: 455-459.
36. Murphy MT, Fraser RH, Goddard JP. Development of a PCR-based diagnostic assay for the determination of KEL genotype in donor blood samples. Transfus Med 1996; 6: 133-137.
37. Avent ND, Martin PG. Kell typing by allele-specific PCR (ASP). Br J Haematol 1996; 93: 728-730.
38. Hessner MJ, McFarland JG, Endean DJ. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. Transfusion 1996; 36: 495-499.
39. Fan E, Levin DB, Glickman BW, Logan DM. Limitations in the use of SSCP analysis. Mutat Res 1993; 288: 85-92.
40. Hayashi K. PCR-SSCP: a method for detection of mutations. GATA 1992; 9: 73-79.
41. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM. 'Cold SSCP': a simple, rapid and nonradioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res 1993; 21: 3637-3642.
42. Kovar H, Jug G, Auer H, Skern T, Blaas D. Two dimensional single-strand conformation polymorphism analysis: a useful tool for the detection of mutations in long DNA fragments. Nucleic Acids Res 1991; 19: 3507-3510.
43. Sekiya T. Detection of mutant sequences by single-strand conformation polymorphism analysis. Mutat Res 1993; 288: 79-83.
44. Roberts RG, Montandon AJ, Bobrow M, Bently DR. Detection of novel genetic markers by mismatch analysis. Nucleic Acids Res 1989; 17: 5961-5971.
45. Saiki RK, Gelfand DH, Stoffel S et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; January: 487-491.
46. Cariello NF, Skopek TR. Mutational analysis using denaturing gradient gel electrophoresis and PCR. Mutat Res 1993; 288: 103-112.
47. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325-10329.
48. Steers F, Wallace M, Johnson P, Carritt B, Daniels G. Denaturing gradient gel electrophoresis: a novel method for determining Rh phenotype from genomic DNA. Br J Haematol 1996; 94: 417-421.
49. b blood group polymorphism. Hum Genet 1995; 95: 407-410.
50. Bennett PR, Le Van Kim C, Colin Y et al. Prenatal determination of foetal RhD type by DNA amplification. N Engl J Med 1993; 329: 607-610.
51. Simsek S, Faas BHW, Bleeker PMM et al. Rapid RhD genotyping by polymerase chain reaction-based amplification of DNA. Blood 1995; 85: 2975-2980.
52. Wolter LC, Hyland CA. Rhesus D genotyping using polymerase chain reaction. Blood 1993; 82: 1682-1683.
53. Faas BHW, Simsek S, Bleeker PMM et al. Rh E/e genotyping by allele-specific primer amplification. Blood 1995; 85(3): 829-832.
54. Le Van Kim C, Mouro I, Brossard Y, Chavinie J, Cartron JP, Colin Y. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease. Br J Haematol 1994; 88: 193-195.
55. Gassner C, Schmarda A, Nussbaumer W, Schonitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood 1996; 88(5): 1852-1856.
56. Stroncek DF, Konz R, Clay ME, Houchins JP, McCullough J. Determination of ABO glycosyltransferase genotypes by use of polymerase chain reaction and restriction enzymes. Transfusion 1995; 35: 231-240.
57. Ugozzoli L, Wallace RB. Application of an allele-specific polymerase chain reaction to the direct determination of ABO blood group genotypes. Genomics 1992; 12: 670-674.
58. Geifman-Holtzman O, Bernstein IM, Berry SM, Bianchi DW, Holtzman EJ. Rapid molecular determination of fetal Rhesus E type. Prenatal Diagnostics 1996; 16: 489-493.
59. Sekizawa A, Watanabe A, Kimura T, Saito H, Yanaihara T, Sato T. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. Obstet Gynecol 1996; 87(4): 501-505.
60. Van Den Veyver IB, Subramanian SB, Hudson KM, Werch J, Moise KJ, Hughes MR. Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet Gynecol 1996; 87(3): 419-422.